Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Other(2)

Detailed Status

unknown2
Completed2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

unknown250%
completed250%

Recent Activity

0 active trials
Showing 4 of 4
completed

Endoscopic Papillectomy for Ampullary Adenomas

NCT03494543
unknownnot_applicable

Endoscopic Resection of Papillary Adenomas; a Novel Treatment Algorithm to Prevent Recurrence - a Pilot-study

NCT06216730
unknown

Efficacy and Safety of Endoscopic Papillectomy in the Treatment of Ampullary Neoplasms.

NCT05690412
completednot_applicable

EP Combined With RFA for Ampullary Neoplasms With Intraductal Biliary Extension

NCT05028465

Clinical Trials (4)

Showing 4 of 4 trials
NCT03494543

Endoscopic Papillectomy for Ampullary Adenomas

Completed
NCT06216730Not Applicable

Endoscopic Resection of Papillary Adenomas; a Novel Treatment Algorithm to Prevent Recurrence - a Pilot-study

Unknown
NCT05690412

Efficacy and Safety of Endoscopic Papillectomy in the Treatment of Ampullary Neoplasms.

Unknown
NCT05028465Not Applicable

EP Combined With RFA for Ampullary Neoplasms With Intraductal Biliary Extension

Completed

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4